Antibody Response to COVID-19 Vaccines in Liver Disease Patients
Condition(s):Chronic Liver DiseaseLast Updated:October 4, 2023Completed
Hide Studies Not Open or Pending
Condition(s):Chronic Liver DiseaseLast Updated:October 4, 2023Completed
Condition(s):Acute Myeloid Leukemia; Myelodysplastic SyndromeLast Updated:June 6, 2023Completed
Condition(s):SARS-CoV-2Last Updated:April 26, 2023Completed
Condition(s):LymphomaLast Updated:May 22, 2018Completed
Condition(s):COVID-19Last Updated:June 24, 2020Unknown status
Condition(s):Prevention of Meningococcal InfectionLast Updated:July 25, 2017Completed
Condition(s):SARS-CoV-2; Serology; StudentsLast Updated:January 31, 2022Completed
Condition(s):COVID-19Last Updated:March 28, 2022Completed
Condition(s):Specific Polysaccharide Antibody DeficiencyLast Updated:October 7, 2015Unknown status
Condition(s):Japanese EncephalitisLast Updated:October 8, 2013Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.